日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety, tolerability, pharmacokinetics, and pharmacodynamics of TG103 injection in participants who are overweight or obese: a randomized, double-blind, placebo-controlled, multiple-dose phase 1b study

TG103注射液在超重或肥胖受试者中的安全性、耐受性、药代动力学和药效学:一项随机、双盲、安慰剂对照、多剂量1b期研究

Lin, Diaozhu; Xiao, Huisheng; Yang, Kexu; Li, Juan; Ye, Suiwen; Liu, Yanqiong; Jing, Shan; Lin, Yang; Yang, Yuanxun; Huang, Lei; Yuan, Jing; Li, Ziyan; Yang, Jinlan; Gao, Huanhuan; Xie, Ying; Xu, Mingtong; Yan, Li

Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer

多项综合分析确定赖氨酸脱甲基酶 KDM 是胰腺癌的潜在治疗靶点

Wan-Jou Shen, Hsuan-Min Kao, Chih-Yang Wang, Rubina Kousar, Jing-Shan Lin, Ching-Chung Ko, Hung-Yun Lin, Hoang Dang Khoa Ta, Gangga Anuraga, Do Thi Minh Xuan, Sachin Kumar, Sanskriti Dey, Ngoc Phung Ly, Wei-Jan Wang

Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects

酪氨酸激酶2抑制剂Deucravacitinib在健康中国受试者中的药代动力学和安全性

Jing, Shan; Lin, Yang; Dockens, Randy; Marchisin, David; He, Bing; Girgis, Ihab G; Chimalakonda, Anjaneya; Murthy, Bindu; Aras, Urvi